Sandeep A Saha

Summary

Publications

  1. ncbi Influence of glycemic control on the development of diabetic cardiovascular and kidney disease
    Sandeep A Saha
    Providence Medical Research Center, Spokane, WA 99204, USA
    Cardiol Clin 28:497-516. 2010
  2. ncbi Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Sandeep A Saha
    Providence Sacred Heart Medical Center, Spokane, WA 99220 2555, USA
    Curr Opin Lipidol 22:270-6. 2011
  3. ncbi Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study
    Sandeep A Saha
    Providence Medical Research Center, Sacred Heart Medical Center, Spokane, WA 99204, USA
    Am J Ther 17:553-8. 2010
  4. ncbi Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials
    Sandeep A Saha
    Department of Internal Medicine, Sacred Heart Medical Center, Spokane, Washington 99220 2555, USA
    Int J Cardiol 141:157-66. 2010

Detail Information

Publications4

  1. ncbi Influence of glycemic control on the development of diabetic cardiovascular and kidney disease
    Sandeep A Saha
    Providence Medical Research Center, Spokane, WA 99204, USA
    Cardiol Clin 28:497-516. 2010
    ..This article discusses the various drug classes used to treat diabetes mellitus, and reviews the current clinical evidence linking glycemic control using these drug classes on diabetic kidney and cardiovascular disease...
  2. ncbi Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Sandeep A Saha
    Providence Sacred Heart Medical Center, Spokane, WA 99220 2555, USA
    Curr Opin Lipidol 22:270-6. 2011
    ....
  3. ncbi Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study
    Sandeep A Saha
    Providence Medical Research Center, Sacred Heart Medical Center, Spokane, WA 99204, USA
    Am J Ther 17:553-8. 2010
    ..Reducing kidney exposure to AGEs may be a mechanism of protection by angiotensin receptor blockade in DKD. AGEs may also impact the diabetic kidney through mechanisms independent of transforming growth factor-??...
  4. ncbi Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials
    Sandeep A Saha
    Department of Internal Medicine, Sacred Heart Medical Center, Spokane, Washington 99220 2555, USA
    Int J Cardiol 141:157-66. 2010
    ..We conducted a systematic review and meta-analysis of long-term randomized controlled trials to evaluate the role of fibrates in the prevention of cardiovascular events in patients with type 2 diabetes mellitus...